Q4 2024 Bionano Genomics Inc Earnings Call Transcript

Mar 31, 2025 / 08:30 PM GMT

Transcript 10-K8-K

Key Points

Positve

Bionano Genomics Inc (BNGO) reported a significant improvement in GAAP gross margin for Q4 2024, rising to 42% from 23% in Q4 2023.
The company successfully reduced its GAAP operating expenses to $15.4 million in Q4 2024 from $27.4 million in Q4 2023, primarily due to cost-saving initiatives.
Consumable sales increased by 14% in 2024, indicating strong demand for Bionano Genomics Inc (BNGO)'s products.
Sales in the Americas and EMEA regions grew by 9% and 10% respectively in 2024, showcasing geographic expansion.
The company extended its cash runway into Q1 2026, providing financial stability and flexibility for future operations.

Negative

Total revenue for Q4 2024 decreased by 24% compared to Q4 2023, reflecting challenges in maintaining sales momentum.
Full-year 2024 GAAP gross margin was only 1%, down from 26% in 2023, due to one-time non-cash adjustments.
The company experienced a reduction in instrument sales by nearly $2 million, impacting overall revenue growth.
Bionano Genomics Inc (BNGO) is not providing guidance on future gross margins due to expected ongoing volatility.
The company is focusing on a smaller group of routine users, which may limit immediate customer base expansion.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BNGO.OQ - Bionano Genomics Inc
Q4 2024 Bionano Genomics Inc Earnings Call
Mar 31, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and welcome to the Bionanana Fourth quarter, 2024 earnings conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good afternoon everyone.

Welcome to the Bio Nano 4th quarter 2024 financial results conference call. Leading the call today is Dr. Eric Holman, CEO and principal financial officer of Bionano, and he is joined by Mark Adam, Bonnano's Vice President of accounting

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.